Description
Trailer Primary hyperoxaluria type 1, Antibody-mediated rejection treatment – now and in the future and Sustainable nephrology
2025-10-0202:05
#51 Monoclonal gammopathy with renal significance, with Jolanta Małyszko
2025-09-1128:47
#50 Onconephrology: A huge subject, with Kenar D. Jhaveri
2025-09-1115:48
#49 Obesity and CKD, with Marieta Theodorakopoulou
2025-09-1123:17
Trailer Obesity and CKD, Onconephrology: A huge subject and Monoclonal gammopathy with renal significance
2025-09-0401:52
#48 Xenotransplantation: Is it for real? with David Cooper
2025-06-1931:01
#47 Infection prophylaxis for renal transplant recipients in 2025, with Ilaria Gandolfini
2025-06-1928:27
#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat
2025-06-1915:43
Trailer Adapting anti-rejection treatment in a failing renal graft, Infection prophylaxis for renal transplant recipients in 2025 and Xenotransplantation: Is it for real?
2025-06-1202:29
#45 Atypical HUS, with Neil Sheerin
2025-05-1532:53
#44 C3 glomerulopathy, with Marina Vivarelli
2025-05-1530:28
#43 IgG4-related disease, with John Stone
2025-05-1536:11
Trailer IgG4-related disease, C3 glomerulonephritis and Atypical HUS
2025-05-0802:01
#42 A patient's view of nephrology, with Malene Deele
2025-04-1033:10
#41 How to anticoagulate CKD patients with Atrial Fibrilation?, with Frida Welander
2025-04-1022:28
#40 Avacopan in ANCA-Associated Vasculitis, with Lorraine Harper
2025-04-1021:57
Trailer A patient's view of nephrology
2025-04-0300:46
Trailer How to anticoagulate CKD patients with Atrial Fibrilation?
2025-04-0300:55
Trailer Avacopan in ANCA-Associated Vasculitis
2025-04-0301:09
#39 Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease, with Adeera Levin
2025-03-1318:11
0.5x
0.8x
1.0x
1.25x
1.5x
2.0x
3.0x
Sleep Timer
Off
End of Episode
5 Minutes
10 Minutes
15 Minutes
30 Minutes
45 Minutes
60 Minutes
120 Minutes